Researcher.Life Logo

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES : Impact Factor & More

eISSN: 1818-0876pISSN: 1818-0876
JournalOpen Access

Key Metrics

Impact Factor
10 - 15
SJR
Q1Pharmacology
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SHENYANG PHARMACEUTICAL UNIV
Language English
Frequency Bi-monthly
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorShenyang Pharmaceutical University
FrequencyBi-monthly
Publication Start Year2006
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

Hypoxia-responsive hybrid nanoparticles loaded with fingolimod and colistin against multidrug-resistant Klebsiella pneumoniae with mature biofilm
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Biomaterials-mediated sequential drug delivery: Emerging trends for wound healing
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
A ROS/photo dual-responsive prodrug unimolecular micelle for boosted cancer immunotherapy
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Critical Quality Attributes of Lipid Nanoparticles and In Vivo Fate
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Exploring the frontier of oral nanomedicine in colorectal cancer therapy: Folate-targeted 5FU-Nisin-Selenium conjugates and probiotic-rich diets as a novel approach
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Hypoxia-responsive hybrid nanoparticles loaded with fingolimod and colistin against multidrug-resistant Klebsiella pneumoniae with mature biofilm
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Biomaterials-mediated sequential drug delivery: Emerging trends for wound healing
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
A ROS/photo dual-responsive prodrug unimolecular micelle for boosted cancer immunotherapy
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Critical Quality Attributes of Lipid Nanoparticles and In Vivo Fate
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences
Exploring the frontier of oral nanomedicine in colorectal cancer therapy: Folate-targeted 5FU-Nisin-Selenium conjugates and probiotic-rich diets as a novel approach
  • 1 Dec 2025
  • Asian Journal of Pharmaceutical Sciences

FAQs on ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES